Engineers Gate Manager’s Acadia Pharmaceuticals ACAD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $866K | Sell |
40,145
-58,759
| -59% | -$1.27M | 0.01% | 1192 |
|
2025
Q1 | $1.64M | Sell |
98,904
-1,044
| -1% | -$17.3K | 0.03% | 784 |
|
2024
Q4 | $1.83M | Sell |
99,948
-33,246
| -25% | -$610K | 0.03% | 665 |
|
2024
Q3 | $2.05M | Buy |
133,194
+25,449
| +24% | +$391K | 0.04% | 645 |
|
2024
Q2 | $1.75M | Sell |
107,745
-96,928
| -47% | -$1.58M | 0.04% | 616 |
|
2024
Q1 | $3.78M | Buy |
+204,673
| New | +$3.78M | 0.1% | 265 |
|
2023
Q4 | – | Sell |
-142,241
| Closed | -$2.96M | – | 1935 |
|
2023
Q3 | $2.96M | Buy |
142,241
+76,880
| +118% | +$1.6M | 0.11% | 241 |
|
2023
Q2 | $1.57M | Sell |
65,361
-11,249
| -15% | -$269K | 0.06% | 455 |
|
2023
Q1 | $1.44M | Buy |
76,610
+57,530
| +302% | +$1.08M | 0.06% | 430 |
|
2022
Q4 | $304K | Sell |
19,080
-16,175
| -46% | -$258K | 0.02% | 1179 |
|
2022
Q3 | $577K | Buy |
35,255
+2,568
| +8% | +$42K | 0.04% | 705 |
|
2022
Q2 | $461K | Buy |
+32,687
| New | +$461K | 0.02% | 1154 |
|
2022
Q1 | – | Sell |
-24,319
| Closed | -$568K | – | 1791 |
|
2021
Q4 | $568K | Buy |
+24,319
| New | +$568K | 0.03% | 966 |
|
2021
Q3 | – | Sell |
-11,030
| Closed | -$269K | – | 1590 |
|
2021
Q2 | $269K | Sell |
11,030
-29,845
| -73% | -$728K | 0.02% | 1204 |
|
2021
Q1 | $1.06M | Buy |
40,875
+32,425
| +384% | +$837K | 0.05% | 565 |
|
2020
Q4 | $452K | Sell |
8,450
-41,790
| -83% | -$2.24M | 0.02% | 1040 |
|
2020
Q3 | $2.07M | Buy |
50,240
+33,688
| +204% | +$1.39M | 0.1% | 286 |
|
2020
Q2 | $802K | Buy |
+16,552
| New | +$802K | 0.04% | 699 |
|
2020
Q1 | – | Sell |
-18,151
| Closed | -$776K | – | 1525 |
|
2019
Q4 | $776K | Buy |
+18,151
| New | +$776K | 0.03% | 775 |
|
2019
Q3 | – | Sell |
-22,550
| Closed | -$603K | – | 1342 |
|
2019
Q2 | $603K | Buy |
+22,550
| New | +$603K | 0.03% | 658 |
|